Dutch-based health firm VSY Biotechnology has developed innovative new intra-articular injections to fight degenerative joint disease, it said on Monday.
The products were developed for orthopedics, physical treatment, and rehabilitation, according to the statement.
The injections, certified by international quality institutions, can only be administrated to patients by medical professionals, the company noted.
The injections were first introduced to orthopedic physicians in 2015.
VSY Biotechnology, a firm specializing in ophthalmology, is among a handful of companies worldwide that can produce intra-articular injections.
According to the company, VSY Biotechnology serves more than 60 countries around the globe, while its product range includes intra-ocular lenses, viscoelastic, cartridge, injector systems, and intra-articular injections.